EUVIMEDEUVIMED entdecken
Crossref

Targeting multidrug resistant Staphylococcus aureus with cationic chlorpromazine‐peptide conjugates

Apurva Panjla, Grace Kaul, Abdul Akhir, Deepanshi Saxena, Saurabh Joshi, Chandrima Modak, Dipti Kumari, Alok Jain, Sidharth Chopra, Sandeep Verma

Chemistry – An Asian Journal · 2023

DOI: 10.1002/asia.202300169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2023. Verfasst von Apurva Panjla und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, 208016, UP, India. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance is a serious public health risk. Its severity is fueled on an unprecedented scale, necessitating the demand for novel antimicrobial scaffolds aimed at novel targets. Herein, we present cationic chlorpromazine peptide conjugates that are rationally intended to targetmultidrug‐resistant (MDR) bacteria. The most potent compound, CPWL , of all the conjugates evaluated, showed promising antibacterial activity against clinical, MDR S. aureus , with no cytotoxicity. The molecular docking experiments confirmed that CPWL possessed a very high affinity for S. aureus enoyl reductase (saFabI). Furthermore, CPWL antibacterial action against saFabI was further corroborated by MD simulation studies. Thus, our findings highlight cationic chlorpromazine as a promising scaffold for the development of saFabI inhibitors to target severe staphylococcal infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsHumansStaphylococcus aureusChlorpromazineMolecular Docking SimulationAnti-Bacterial AgentsPeptidesMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Antimicrobial resistanceantibioticsmembrane proteinspeptide

Substanzen

ChlorpromazineAnti-Bacterial AgentsPeptides

Autor:innen und Institutionen

  • Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, 208016, UP, India.
  • Department of Molecular Microbiology and Immunology, CSIR-Central Drug Research Institute, Sector 10, Sitapur Road, Janakipuram Extension, Lucknow, 226031, UP, India.
  • AcSIR: Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Mehta Family Center for Engineering in Medicine, Center for Nanoscience, Indian Institute of Technology Kanpur, Kanpur, 208016, UP, India.
  • Department of Bioengineering and Biotechnology, Birla Institute of Technology Mesra, Ranchi, 835215, Jharkhand, India.

Zitieren

APA

Panjla, A., Kaul, G., Akhir, A., Saxena, D., Joshi, S., Modak, C., Kumari, D., Jain, A., Chopra, S., & Verma, S. (2023). Targeting multidrug resistant Staphylococcus aureus with cationic chlorpromazine‐peptide conjugates. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202300169

Vancouver

Panjla A, Kaul G, Akhir A, Saxena D, Joshi S, Modak C, et al. Targeting multidrug resistant Staphylococcus aureus with cationic chlorpromazine‐peptide conjugates. Chemistry – An Asian Journal. 2023. doi:10.1002/asia.202300169

BibTeX
@article{Panjla2023,
  author = {Panjla, Apurva and Kaul, Grace and Akhir, Abdul and Saxena, Deepanshi and Joshi, Saurabh and Modak, Chandrima and Kumari, Dipti and Jain, Alok and Chopra, Sidharth and Verma, Sandeep},
  title = {Targeting multidrug resistant Staphylococcus aureus with cationic chlorpromazine‐peptide conjugates},
  journal = {Chemistry – An Asian Journal},
  year = {2023},
  doi = {10.1002/asia.202300169}
}
Kostenlos starten →